One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Tackling the burden of digestive disorders in Europe
doi : 10.1016/S2468-1253(22)00431-9
Volume 8, Issue 2, February 2023, Page 95
Another arrow in the NASH quiver?
Roberta Forlano, *Pinelopi Manousou
doi : 10.1016/S2468-1253(22)00383-1
Volume 8, Issue 2, February 2023, Pages 96-97
Low intensity treatment in metastatic colorectal cancer
Hui-Li Wong, *Jeanne Tie
doi : 10.1016/S2468-1253(22)00380-6
Volume 8, Issue 2, February 2023, Pages 97-99
Working towards a comprehensive appraisal of vaccine-induced immunity against SARS-CoV-2 in IBD
Antonius T Otten, Arno R Bourgonje, *Marijn C Visschedijk
doi : 10.1016/S2468-1253(22)00404-6
Volume 8, Issue 2, February 2023, Pages 99-100
Lessons and open questions in borderline resectable pancreatic cancer
*Michele Reni, Giulia Orsi
doi : 10.1016/S2468-1253(22)00393-4
Volume 8, Issue 2, February 2023, Pages 101-102
Local and systemic therapy in liver cancer: the quest for synergy
*Matthias Pinter, David J Pinato
doi : 10.1016/S2468-1253(22)00350-8
Volume 8, Issue 2, February 2023, Pages 102-104
Terlipressin for hepatorenal syndrome: opportunities and challenges
*Ashwani K Singal, Rajiv Jalan
doi : 10.1016/S2468-1253(22)00377-6
Volume 8, Issue 2, February 2023, Pages 104-106
Palliative care in advanced liver disease: time for action
*Sumita Verma, Julia Verne, Nneka N Ufere
doi : 10.1016/S2468-1253(22)00382-X
Volume 8, Issue 2, February 2023, Pages 106-108
Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection
Joffrey van Prehn, Fidelma Fitzpatrick, Ed J Kuijper, on behalf of the European Study Group for Clostridioides difficile and the European Study Group for Host and Microbiota Interaction
doi : 10.1016/S2468-1253(22)00342-9
Volume 8, Issue 2, February 2023, Page 109
Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection
*Simon D Goldenberg, Blair Merrick
doi : 10.1016/S2468-1253(22)00343-0
Volume 8, Issue 2, February 2023, Pages 109-110
Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection
Elizabeth S Aby, Radha Rajasingham, Eva A Enns, *Byron P Vaughn
doi : 10.1016/S2468-1253(22)00353-3
Volume 8, Issue 2, February 2023, Pages 110-111
Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection
Marcela Krutova, Kerrie Davis, Benoit Guery, Frédéric Barbut
doi : 10.1016/S2468-1253(22)00388-0
Volume 8, Issue 2, February 2023, Pages 111-112
Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection – Authors' reply
Simon Mark Dahl Baunwall, Sara Ellegaard Andreasen, Mette Mejlby Hansen, Jens Kelsen, Katrine Lundby Høyer, Nina Rågård, Lotte Lindgreen Eriksen, Sidsel Støy, Tone Rubak, Else Marie Skjøde Damsgaard, Susan Mikkelsen, Christian Erikstrup,Jens Frederik Dahlerup, Christian Lodberg Hvas
doi : 10.1016/S2468-1253(22)00424-1
Volume 8, Issue 2, February 2023, Pages 112-113
Peroral endoscopic myotomy versus pneumatic dilation in treatment-naive patients with achalasia
*Fei Zhang, Chunlin Ge
doi : 10.1016/S2468-1253(22)00378-8
Volume 8, Issue 2, February 2023, Pages 113-114
Peroral endoscopic myotomy versus pneumatic dilation in treatment-naive patients with achalasia – Authors' reply
Thijs Kuipers, *Albert J Bredenoord
doi : 10.1016/S2468-1253(22)00423-X
Volume 8, Issue 2, February 2023, Page 114
An Australian perspective on monkeypox virus and stool transplants
Bryant Koh, Anthea Cheng, Khin Chaw, Iain B Gosbell
doi : 10.1016/S2468-1253(22)00403-4
Volume 8, Issue 2, February 2023, Pages 114-115
An open letter to Gavi: hepatitis B birth dose vaccine can't wait
CDA Foundation; Coalition for Global Hepatitis Elimination, Hepatitis Australia, The Hepatitis Fund; Hepatitis B Foundation, Médecins Sans Frontières Access Campaign, PATH, TREAT Asia/amfAR, The Foundationfor AIDS Research, Union for International Cancer Control, *World Hepatitis Alliance
doi : 10.1016/S2468-1253(22)00422-8
Volume 8, Issue 2, February 2023, Pages 115-116
Correction to Lancet Gastroenterol Hepatol 2023; 8: 81–94
doi : 10.1016/S2468-1253(22)00429-0
Volume 8, Issue 2, February 2023, Page 117
Research in Brief
Holly Baker
doi : 10.1016/S2468-1253(22)00432-0
Volume 8, Issue 2, February 2023, Page 118
Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study
Rohit Loomba, Eric J Lawitz, Juan Pablo Frias, Grisell Ortiz-Lasanta, Lars Johansson, Bridgette Boggess Franey, Linda Morrow, Moti Rosenstock*, Cynthia L Hartsfield, Chao-Yin Chen, Leo Tseng, R Will Charlton, Hank Mansbach, Maya Margalit
doi : 10.1016/S2468-1253(22)00347-8
Volume 8, Issue 2, February 2023, Pages 120-132
Trifluridine–tipiracil plus bevacizumab versus capecitabine plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer ineligible for intensive therapy (SOLSTICE): a randomised, open-label phase 3 study
Thierry André, Alfredo Falcone, Yaroslav Shparyk, Fedor Moiseenko, Eduardo Polo-Marques, Tibor Csöszi, Arinilda Campos-Bragagnoli, Gabor Liposits, Ewa Chmielowska, Paul Aubel, Lourdes MartÃn, Ronan Fougeray, Nadia Amellal, Mark P Saunders
doi : 10.1016/S2468-1253(22)00334-X
Volume 8, Issue 2, February 2023, Pages 133-144
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study
Zhigang Liu, Kaixing Le, Xin Zhou, James L Alexander, Simeng Lin, Claire Bewshea, Neil Chanchlani, Rachel Nice, Timothy J McDonald, Christopher A Lamb, Shaji Sebastian, Klaartje Kok, Charlie W Lees, Ailsa L Hart, Richard C Pollok, Rosemary J Boyton, Daniel M Altmann, Katrina M Pollock, James R Goodhand, Nicholas A Kennedy, Tariq Ahmad*, Nick Powell*, on behalf of the CLARITY study investigatorsâ€
doi : 10.1016/S2468-1253(22)00389-2
Volume 8, Issue 2, February 2023, Pages 145-156
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial
Paula Ghaneh, Daniel Palmer, Silvia Cicconi, Richard Jackson, Christopher Michael Halloran, Charlotte Rawcliffe, Rajaram Sripadam, Somnath Mukherjee, Zahir Soonawalla, Jonathan Wadsley, Ahmed Al-Mukhtar, Euan Dickson, Janet Graham, Long Jiao, Harpreet S Wasan, Iain S Tait, Andreas Prachalias, Paul Ross, Juan W Valle, Derek A O’Reilly, Bilal Al-Sarireh, Sarah Gwynne, Irfan Ahmed, Kate Connolly, Kein-Long Yim, David Cunningham, Thomas Armstrong, Caroline Archer, Keith Roberts, Yuk Ting Ma, Christoph Springfeld, Christine Tjaden, Thilo Hackert, Markus W Büchler, John P Neoptolemos, for the European Study Group for Pancreatic Cancer
doi : 10.1016/S2468-1253(22)00348-X
Volume 8, Issue 2, February 2023, Pages 157-168
Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial
Chi Leung Chiang*, Keith Wan Hang Chiu, Kenneth Sik Kwan Chan, Francis Ann Shing Lee, James Chun Bong Li, Catherine Wing Suet Wan, Wing Chiu Dai, Tai Chung Lam, Wenqi Chen, Natalie Sean Man Wong, Andy Lai Yin Cheung, Venus Wan Yan Lee, Vince Wing Hang Lau, Aya El Helali, Kwan Man, Feng Ming (Spring) Kong, Chung Mau Lo, Albert Chi-Yan Chan*
doi : 10.1016/S2468-1253(22)00339-9
Volume 8, Issue 2, February 2023, Pages 169-178
Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease
Giovanni Targher, Alessandro Mantovani, Christopher D Byrne
doi : 10.1016/S2468-1253(22)00338-7
Volume 8, Issue 2, February 2023, Pages 179-191
New hepatitis B drug development disillusions: time to reset?
Jean-Michel Pawlotsky
doi : 10.1016/S2468-1253(22)00341-7
Volume 8, Issue 2, February 2023, Pages 192-197
An unusual complication after a variceal glue injection
James A Morgan, Ankit Arora, Thazin Min, Christy Riggott, Fathallah Islim, Jayne Dillon
doi : 10.1016/S2468-1253(22)00406-X
Volume 8, Issue 2, February 2023, Page 198
